RLI CEO awarded options on 22,500 shares
RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant. He received options covering 22,500 shares of common stock at an exercise price of $49.88 per share. The options expire on May 14, 2034 and vest in 20% increments annually, beginning one year after the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 22,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.
Key Figures
Key Terms
Stock Option financial
exercise price financial
expiration date financial
grant/award acquisition financial
vesting schedule financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RLI (RLI) CEO Craig Kliethermes report in this Form 4?
What is the exercise price of the RLI (RLI) CEO’s new options?
When do Craig Kliethermes’ RLI (RLI) options vest and expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.